The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity.
Study Design
- अध्ययन प्रकार
- In Vitro
- जनसंख्या
- Neonatal rat brainstem preparation
- हस्तक्षेप
- The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Valerian extract 3 mg/mL; valerenic acid 100 uM
- तुलनित्र
- Muscimol (GABA-A agonist)
- प्राथमिक परिणाम
- Brainstem neuronal firing rate inhibition
- प्रभाव की दिशा
- Positive
- पूर्वाग्रह का जोखिम
- Unclear
Abstract
UNLABELLED: Valerian is a medicinal herb that produces anxiolytic and sedative effects. It was suggested that valerian acts via gamma-aminobutyric acid (GABA)ergic mechanisms. Previous studies showed binding of valerian extract to GABA receptors, but the functional effect of the binding has not been demonstrated. In this study we evaluated the GABAergic effect of valerian extract and one of its major constituents, valerenic acid, on brainstem neuronal activity in an in vitro neonatal rat brainstem preparation. We first observed that muscimol, a GABA(A) receptor agonist, decreased the firing rate in most brainstem neurons in a concentration-related fashion; 30 micro M produced a 38.9% +/- 3.0% (mean +/- SE) inhibition compared with control values (P < 0.01; 50% inhibitory concentration [IC(50)], 2.0 +/- 0.1 microM). This effect was antagonized by bicuculline (10 microM), a GABA(A) antagonist. Then we showed that valerian extract 3 mg/mL induced a 29.6% +/- 5.1% inhibition with an IC(50) of 240 +/- 18.7 microg/mL, whereas 100 microM valerenic acid induced a 22.2% +/- 3.4% inhibition with an IC(50) of 23 +/- 2.6 microM (both P < 0.01). Bicuculline antagonized the inhibitory effects of both the valerian extract and valerenic acid. In addition, pretreatment with valerian extract or valerenic acid decreased the brainstem inhibitory effects produced by muscimol (both P < 0.05), suggesting that these compounds play an important role in the regulation of GABAergic activity. Data from this study suggest that the pharmacological effects of valerian extract and valerenic acid are mediated through modulation of GABA(A) receptor function. Thus, valerian may potentiate the sedative effects of anesthetics and other medications that act on GABA receptors, and presurgical valerian use may cause a valerian-anesthetic interaction. IMPLICATIONS: Valerian is an herb used in treating anxiety and insomnia. We observed that the valerian effects are mediated through brain gamma-aminobutyric acid (GABA) receptors in a rat brainstem preparation. Thus, valerian may potentiate the effects of anesthetics that act on GABA receptors, and presurgical valerian use may cause a valerian-anesthetic interaction.
संक्षेप में
Valerian may potentiate the sedative effects of anesthetics and other medications that act on GABA receptors, and presurgical valerian use may cause a Valerian-anesthetic interaction.
Used In Evidence Reviews
Similar Papers
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2017
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
The American journal of medicine · 2006
Valerian for sleep: a systematic review and meta-analysis.
Clinical therapeutics · 2016
Review of Safety and Efficacy of Sleep Medicines in Older Adults.
Sleep medicine reviews · 2011
A systematic review of insomnia and complementary medicine.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 1999
Unsafe and potentially safe herbal therapies.
Sleep medicine · 2000